N-isovalerylglycine,
N-Isovaleroylglycine,
16284-60-9,
2-(3-Methylbutanamido)acetic acid,
N-Isovalerylglycine,
Isovalerylglycine,
[(3-Methylbutanoyl)amino]acetic acid,
N-(3-methylbutanoyl)glycine,
2-[(3-Methylbutanoyl)amino]acetic acid,
ZRQXMKMBBMNNQC-UHFFFAOYSA-N,
2-(3-Methyl-Butanamido)Acetic Acid,
2-(3-methylbutanoylamino)ethanoic acid,
Isovaleroylglycine,
isopentanoylglycine,
N-isopentanoylglycine,
N-isovaleryl-glycine,
3-Methylbutyrylglycine,
ACMC-209doz,
AC1LC1S1,
SCHEMBL622444,
AC1Q1P36,
(3-methylbutanamido)acetic acid,
CHEBI:70984,
CTK0H3559,
KS-00000ACP,
(3-methylbutyrylamino)acetic acid,
[(3-methylbutanoyl)amino]acetate,
DTXSID00338092,
2-(3-methylbutanoylamino)ethanoate,
ZINC2527898,
8261AA,
ANW-22017,
MFCD00059629,
2-(3-methylbutanoylamino)acetic acid,
Glycine, N-(3-methyl-1-oxobutyl)-,
AKOS000128580,
CS-W016180,
HY-W015464,
[(3-Methylbutanoyl)amino]acetic acid #,
N-Isovalerylglycine, >=97.0% (GC),
AJ-38188,
AK-61155,
AS-10597,
SY040457,
TR-066243,
4CH-024787,
BB 0259545,
FT-0670570,
I0301,
ST24039330,
MFCD00059629 (97%),
[(3-Methylbutanoyl)amino]acetic acid, AldrichCPR,
J-009980,
I14-35683,
N-Iso Valerylglycine,
C7H13NO3,
CID546304,